Skip to content
The Policy VaultThe Policy Vault

lenalidomide — Medica

Myelofibrosis with anemia and del(5q)

Initial criteria

  • age ≥ 18 years
  • according to the prescriber, patient has anemia with presence of del(5q)
  • medication used in combination with prednisone

Approval duration

1 year